Harnessing HIV for Good

Throughout his career, Inder Verma has turned unexpected results into important advances

Written byKaren Hopkin
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

As a graduate student at the Weizmann Institute in 1967, Inder Verma set out to study mitochondrial RNA from animal cells. At the time, culturing cells was a challenge. "We had to go to the butcher to get blood, then separate serum to grow cells," he recalls. But Verma soon faced an even bigger problem. "In Israel, there were a lot of orange orchards, and they had a lot of fungi," he explains. "So every plate had this gigantic green fungus on it." Undaunted, Verma ground up all the material at hand and purified mitochondrial RNA - from the fungus. "It was a great piece of luck," says Verma, now at the Salk Institute for Biological Studies in La Jolla, Calif. No one had ever studied the properties of fungal mitochondrial RNA. "It was a very successful PhD. I had lots and lots of papers."

But more than luck, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies